Martin H. Huber Jr.
Director · ACTUATE THERAPEUTICS, INC.
- 2025
- May 22, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Martin H. Huber Jr. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Todd S. Thomson - $1.62M in ACTU purchases and sales in the last 12 months
- Michael A. Metzger - $1.43M in SNDX purchases and sales in the last 12 months
- Nicholas A.J. Botwood - $1.18M in SNDX purchases and sales in the last 12 months
- Keith A. Goldan - $137K in SNDX purchases and sales in the last 12 months
- Mohan Bala - $762 in MRSN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Martin H. Huber Jr.?
Martin H. Huber Jr. is a corporate insider, tracked as Director of ACTUATE THERAPEUTICS, INC. (ACTU). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Martin H. Huber Jr. last file a Form 4?
The most recent primary Form 4 on record is dated 22 May 2026, one of 3 filings going back to 2025.
Has Martin H. Huber Jr. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($15K) across all tracked filings.
